RAB5C and cancer: Whilst this study explores productive uptake of ASO across several clinically relevant cancer models, further work across other tumours types, in vivo models (e.g. in cell-derived and patient-derived xenograft (PDX) models), as well as normal cells and tissues, would help understand if Rab5C function in productive uptake is universally conserved.